Dermata Therapeutics DRMAW Stock
Dermata Therapeutics Price Chart
Dermata Therapeutics DRMAW Financial and Trading Overview
| Dermata Therapeutics stock price | 0.01 USD |
| Previous Close | 0.01 USD |
| Open | 0.02 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.01 USD |
| Volume | 7K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.156 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DRMAW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.006900878 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Dermata Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.69 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
DRMAW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 3.17M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.66% |
| Return on Equity (ttm) | -103.58% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7102676 USD |
| Diluted EPS (ttm) | -2.156 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.95M USD |
| Total Cash Per Share (mrq) | 1.73 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.092 |
| Book Value Per Share (mrq) | 1.594 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8303211 USD |
| Levered Free Cash Flow (ttm) | -6336057 USD |
Profile of Dermata Therapeutics
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3525 Del Mar Heights Rd. |
| ZIP | 92130 |
| Phone | 858 800 2543 |
| Website | https://www.dermatarx.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 9 |
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Q&A For Dermata Therapeutics Stock
What is a current DRMAW stock price?
Dermata Therapeutics DRMAW stock price today per share is 0.01 USD.
How to purchase Dermata Therapeutics stock?
You can buy DRMAW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dermata Therapeutics?
The stock symbol or ticker of Dermata Therapeutics is DRMAW.
How many shares does Dermata Therapeutics have in circulation?
The max supply of Dermata Therapeutics shares is 0.
What is Dermata Therapeutics Price to Earnings Ratio (PE Ratio)?
Dermata Therapeutics PE Ratio is now.
What was Dermata Therapeutics earnings per share over the trailing 12 months (TTM)?
Dermata Therapeutics EPS is -2.156 USD over the trailing 12 months.